Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma.

Zahra AlipourDiana Agostini-VulajJennifer Findeis-HoseyLei LiuRaul S GonzalezMichael G DrageHannah KrigmanZhongren Zhou

Published in: Clinical and experimental gastroenterology (2021)

Mannose may be a particularly useful adjunct with chemotherapy to treat this aggressive subgroup. PMI expression is also a potential biomarker to predict the prognosis of PDAC.

Keyphrases

poor prognosis
binding protein
long non coding rna
randomized controlled trial
squamous cell carcinoma
phase iii
chemotherapy induced